Matches in SemOpenAlex for { <https://semopenalex.org/work/W2072328760> ?p ?o ?g. }
- W2072328760 endingPage "7937" @default.
- W2072328760 startingPage "7929" @default.
- W2072328760 abstract "Abstract Purpose: Both [131I]meta-iodobenzylguanidine ([131I]MIBG) and the topoisomerase I inhibitor topotecan are effective as single-agent treatments of neuroblastoma. The aim of this study was to investigate the efficacy of [131I]MIBG in combination with topotecan in vitro and in vivo. Experimental Design: The cell lines used were SK-N-BE(2c) (human neuroblastoma) and UVW/NAT (glioma cell line transfected with the noradrenaline transporter gene). Three different treatment schedules were assessed: topotecan given before (schedule 1), after (schedule 2), or simultaneously (schedule 3) with [131I]MIBG. DNA strand breakage was evaluated by comet assay, and cytotoxicity was determined by clonogenic survival. Efficacy was also measured by growth delay of tumor xenografts in nude mice. Results: Combination schedules 2 and 3 caused more cytotoxicity than schedule 1. Similarly, significant DNA damage was observed following treatment schedules 2 and 3 (P < 0.005) but not schedule 1. The mean number of days for a doubling in volume of SK-N-BE(2c) tumors and a 10-fold increase in volume of UVW/NAT tumors were 10.4 and 18.6 (untreated), 19.7 and 25.3 (topotecan alone), 22.8 and 31.9 ([131I]MIBG alone), 26.3 and 37.1 (combination schedule 1), 34.3 and 49.7 (combination schedule 2), and 53.2 and >71 (combination schedule 3), respectively. The highest rate of cure of both xenografts was observed following treatment with combination schedule 3. Conclusions: The combination of topotecan and [131I]MIBG compared with either treatment alone gave rise to greater than additive DNA damage, clonogenic cell kill, and tumor growth delay. These effects were dependent on the scheduling of the two agents." @default.
- W2072328760 created "2016-06-24" @default.
- W2072328760 creator A5009313090 @default.
- W2072328760 creator A5021978395 @default.
- W2072328760 creator A5029520063 @default.
- W2072328760 creator A5047736975 @default.
- W2072328760 creator A5060892126 @default.
- W2072328760 creator A5064732539 @default.
- W2072328760 creator A5084998626 @default.
- W2072328760 creator A5085027673 @default.
- W2072328760 date "2005-11-01" @default.
- W2072328760 modified "2023-10-17" @default.
- W2072328760 title "[131I]<i>meta</i>-Iodobenzylguanidine and Topotecan Combination Treatment of Tumors Expressing the Noradrenaline Transporter" @default.
- W2072328760 cites W1966496128 @default.
- W2072328760 cites W1967920937 @default.
- W2072328760 cites W1971404503 @default.
- W2072328760 cites W1974514766 @default.
- W2072328760 cites W1974767963 @default.
- W2072328760 cites W1982362362 @default.
- W2072328760 cites W1988529521 @default.
- W2072328760 cites W1995919013 @default.
- W2072328760 cites W2000233847 @default.
- W2072328760 cites W2007964252 @default.
- W2072328760 cites W2010956382 @default.
- W2072328760 cites W2014753595 @default.
- W2072328760 cites W2015070625 @default.
- W2072328760 cites W2022940390 @default.
- W2072328760 cites W2025852780 @default.
- W2072328760 cites W2028185348 @default.
- W2072328760 cites W2033485414 @default.
- W2072328760 cites W2045042890 @default.
- W2072328760 cites W2046209641 @default.
- W2072328760 cites W2051488635 @default.
- W2072328760 cites W2052959198 @default.
- W2072328760 cites W2054450704 @default.
- W2072328760 cites W2056956487 @default.
- W2072328760 cites W2068830230 @default.
- W2072328760 cites W2071754363 @default.
- W2072328760 cites W2077945404 @default.
- W2072328760 cites W2091158789 @default.
- W2072328760 cites W2099595985 @default.
- W2072328760 cites W2107504931 @default.
- W2072328760 cites W2130959511 @default.
- W2072328760 cites W2142214316 @default.
- W2072328760 cites W2146935608 @default.
- W2072328760 cites W2148387628 @default.
- W2072328760 cites W2150400603 @default.
- W2072328760 cites W2159103399 @default.
- W2072328760 cites W2335608256 @default.
- W2072328760 cites W2422809903 @default.
- W2072328760 cites W2479044294 @default.
- W2072328760 doi "https://doi.org/10.1158/1078-0432.ccr-05-0982" @default.
- W2072328760 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16278418" @default.
- W2072328760 hasPublicationYear "2005" @default.
- W2072328760 type Work @default.
- W2072328760 sameAs 2072328760 @default.
- W2072328760 citedByCount "61" @default.
- W2072328760 countsByYear W20723287602012 @default.
- W2072328760 countsByYear W20723287602013 @default.
- W2072328760 countsByYear W20723287602014 @default.
- W2072328760 countsByYear W20723287602015 @default.
- W2072328760 countsByYear W20723287602016 @default.
- W2072328760 countsByYear W20723287602017 @default.
- W2072328760 countsByYear W20723287602018 @default.
- W2072328760 countsByYear W20723287602019 @default.
- W2072328760 countsByYear W20723287602020 @default.
- W2072328760 countsByYear W20723287602021 @default.
- W2072328760 countsByYear W20723287602022 @default.
- W2072328760 countsByYear W20723287602023 @default.
- W2072328760 crossrefType "journal-article" @default.
- W2072328760 hasAuthorship W2072328760A5009313090 @default.
- W2072328760 hasAuthorship W2072328760A5021978395 @default.
- W2072328760 hasAuthorship W2072328760A5029520063 @default.
- W2072328760 hasAuthorship W2072328760A5047736975 @default.
- W2072328760 hasAuthorship W2072328760A5060892126 @default.
- W2072328760 hasAuthorship W2072328760A5064732539 @default.
- W2072328760 hasAuthorship W2072328760A5084998626 @default.
- W2072328760 hasAuthorship W2072328760A5085027673 @default.
- W2072328760 hasBestOaLocation W20723287601 @default.
- W2072328760 hasConcept C109316439 @default.
- W2072328760 hasConcept C117262875 @default.
- W2072328760 hasConcept C126322002 @default.
- W2072328760 hasConcept C143998085 @default.
- W2072328760 hasConcept C185592680 @default.
- W2072328760 hasConcept C202751555 @default.
- W2072328760 hasConcept C207001950 @default.
- W2072328760 hasConcept C2776694085 @default.
- W2072328760 hasConcept C2776715637 @default.
- W2072328760 hasConcept C2776999253 @default.
- W2072328760 hasConcept C2781209748 @default.
- W2072328760 hasConcept C502942594 @default.
- W2072328760 hasConcept C54355233 @default.
- W2072328760 hasConcept C55493867 @default.
- W2072328760 hasConcept C71924100 @default.
- W2072328760 hasConcept C81885089 @default.
- W2072328760 hasConcept C86803240 @default.
- W2072328760 hasConcept C98274493 @default.
- W2072328760 hasConceptScore W2072328760C109316439 @default.